LIFE LIFE
Company Profile ↓Company Overview
LIFE (LIFE) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Return on capital employed stands at 18.1%.
Net profit has compounded at 549.0% per year over the last five years.
Revenue has grown at a 55.8% CAGR over the past five years.
Maintains a net profit margin of 18.4%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $387.61M (+52.0% YoY); net profit $71.15M.
- Trailing 12 Months Year-on-year growth — revenue +52.0%, earnings +45.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 55.8%, profit CAGR 549.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 55.77% |
| 1 Year: | 52.05% |
Compounded Profit Growth
| 5 Years: | 549.05% |
| 1 Year: | 45.71% |
Stock Price Performance
| 1 Year: | +64.51% |
| 6 Months: | +117.75% |
| 3 Months: | +31.69% |
| 1 Month: | +42.52% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- RSI (14)79.32 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 55.8% over 5 years.
- Profit CAGR of 549.0% over 5 years.
- Generates positive free cash flow.
CONS
- RSI at 79 suggests overbought conditions.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue | 94.89M | 193.10M |
| Operating Income | 12.54M | -163.31M |
| Net Income | 12.25M | -166.39M |
| Diluted EPS | 0.21 | -3.57 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 159.75M | 254.93M | 387.61M |
| Cost of Revenue | 5.90M | 6.53M | 6.73M |
| Gross Profit | 153.85M | 248.40M | 380.88M |
| Operating Expenses | 156.76M | 199.65M | 307.95M |
| Operating Income | -2.91M | 48.75M | 72.92M |
| EBITDA | 8.71M | 60.01M | 85.18M |
| Interest Expense | 723.00K | 595.00K | 3.17M |
| Pretax Income | 2.27M | 53.94M | 75.74M |
| Tax Provision | 586.00K | 5.10M | 4.59M |
| Net Income | 1.69M | 48.83M | 71.15M |
| Diluted EPS | 0.03 | 0.78 | 1.14 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Total Assets | - | 395.88M | 515.34M |
| Total Equity | -159.18M | -107.15M | -24.12M |
| Cash & Equivalents | - | 35.08M | 91.09M |
| Total Liabilities | - | 99.03M | 135.46M |
| Current Liabilities | - | 67.60M | 113.19M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2024 | Dec 2025 |
|---|---|---|
| Operating Cash Flow | -10.91M | 36.23M |
| Investing Cash Flow | -896.00K | 31.87M |
| Financing Cash Flow | 21.86M | -12.05M |
| Capital Expenditure | -776.00K | -1.49M |
| Free Cash Flow | -11.68M | 34.73M |
| Dividends Paid | - | 0 |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | 96.3% | 97.4% | 98.3% |
| Operating Margin % | -1.8% | 19.1% | 18.8% |
| Net Margin % | 1.1% | 19.2% | 18.4% |
| ROE % | -1.1% | -45.6% | -295.0% |
| ROCE % | - | 14.8% | 18.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for LIFE
Sandisk’s stock falls as the company’s forecast doesn’t live up to high expectations - MarketWatch
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSmJUQVViaHdZTjl4SFdqZDdvRkRTeER6X0JiX2RNVXpoUzdEc3RBbmxidkxIalB4NlVVVEV0LURqMUg2bVgtbGVoS0lFSnc2LThseDFVdmFtcHltTGdSLVdndW1HYkliTzFBdWluYld5c0Z3X25QcGdLWk1uNlNNZzFjbHhTZXF2ZFF4TH…
New World Screwworm | Animal and Plant Health Inspection Service - aphis.usda.gov
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxNcnp4eEc5X1JGV3llb18xS1hMekV6bXNSWjhDWjhIb2d0ZnlEaExqalh6WTAwMV9xYzJSNFZoeDJFZmdOYmJ2WGt3RXBrbkZKYmc1ckF1aVFBNjRNX2Jpbm0taWRLeGR3MWN1czFiQVg2UXA1ZnhnWWIwTm5sZDFjeA?oc=5" target="_…
$LIFE stock is up 12% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPSklmb2RnYzdPcVNYdlhTNDFOWlQxeFNNY0xValVXRURxcFlZZWVfeUI1b3ZDbFlxT2JWQjVLRlZZdW8yRldRR1pLd2ZoazktNENRTlNtRzVZeXczVHI1Si1VX3dNTmZmY3dueTdHTXd6amdWTlhnOUdMaWN3TFQxV290Q0dNV3VrV1ZVcz…
Ethos Technologies (LIFE) Stock Jumps As Profit Arrives And Growth Roars - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxPS0M3SmtkaGtLeHFKVGh5LWxkeW9MalVhODJqOWN0cFZ2OGl6RXFCNTZGcHB2Um1MSDFWN09ub1JyN3ozWXhoalFfVFpzS1VKUlAyOVhEMUlqZTIteWFKczdpV2IyYnQwT2JmZWpUYXhfbVlOUkZ2dTk0NVJCaDIyZWZiMGRiQ0Z1SFA3d0…
These Analysts Boost Their Forecasts On Ethos Technologies Following Upbeat Q2 Results - Benzinga
<a href="https://news.google.com/rss/articles/CBMi8wFBVV95cUxOZ216bWhSOUt1WmZJYW44QWhFTy1aTjhUOGUxQW9MY3BZbFhIcnNYS3FNcF9VdTAyNjZUSHotclJ4X0lCOHhEYXI5Nzl6Znc2M0t2NzJ6OEp1VUJ4OWdNbDYzcWN2UEs5dXN0WWQ3VnBmaDBHcXVYbnFhUkdZeTlvR1hNSGN5VWtEX3dyVk…
Barclays Forecasts Strong Price Appreciation for Ethos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) Stock - MarketBeat
<a href="https://news.google.com/rss/articles/CBMi9gFBVV95cUxQZmFsbGRfLVVZbU5TR2JvVUFLcnlmVFlXQ09tWG14WGdsMmVCR2xMZnFBalpzVTk3WVhLNi1tdGQ2ZjdnVlZWWXBWanVmOU5QbklFNUxPejRXdU43cFU3S1I1X2Z4cXR0Ujg3Rnhzam4xUTRMbnIwM0dvSWZYRHRJVEhnMUJzSlYydi01bk…
LIFE — Frequently Asked Questions
What is the current share price of LIFE?
As of 2026-08-05 17:25 PDT, LIFE trades at $27.72 on NASDAQ/NYSE. Its 52-week range is $9.85 to $30.59.
What is the P/E ratio of LIFE?
LIFE trades at a trailing price-to-earnings (P/E) ratio of 24.37.
Is LIFE a good stock to buy?
This page provides a data-driven analysis of LIFE, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.